摘要
研究表明，以肿瘤血管形成的各个环节为靶点的抗血管治疗药物，可以有效抑制乳腺癌的生长、浸润和转移，且具有高效、不良反应小、不易耐药等优点，现已成为乳腺癌治疗领域的研究热点。
It has recently been demonstrated that anti-angiogenesis drugs targeting every possible as- pect of tumor angiogenesis effectively inhibit the growth, invasion and metastasis of breast cancer with low side-effects and drug resistance. These types of anti-angiogenesis drugs have become a hotspot in the field of breast cancer research.
出处
《国际肿瘤学杂志》
CAS
2010年第6期442-444,共3页
Journal of International Oncology
基金
大连市科技局社会发展计划（2007E21SF197）
